Table 9 KEGG pathway analysis of DEGs expressed only in group A & SA, not in other groups
Pathway ID | Pathway | DEGs with pathway annotation (300) | P-value |
|---|---|---|---|
ko04514 | Cell adhesion molecules (CAMs) | 38(12.67%) | 7.04E-06 |
ko04144 | Endocytosis | 38(12.67%) | 5.67E-05 |
ko05168 | Herpes simplex infection | 38(12.67%) | 2.46E-10 |
ko05169 | Epstein-Barr virus infection | 37(12.33%) | 8.96E-11 |
ko05203 | Viral carcinogenesis | 37(12.33%) | 1.99E-09 |
ko04145 | Phagosome | 34(11.33%) | 1.88E-09 |
ko05166 | HTLV-I infection | 34(11.33%) | 2.38E-05 |
ko05416 | Viral myocarditis | 34(11.33%) | 2.91E-14 |
ko04612 | Antigen processing and presentation | 30(10.00%) | 3.52E-14 |
ko05320 | Autoimmune thyroid disease | 29(9.67%) | 1.94E-13 |
ko04940 | Type I diabetes mellitus | 28(9.33%) | 7.70E-13 |
ko05330 | Allograft rejection | 28(9.33%) | 1.86E-13 |
ko05332 | Graft-versus-host disease | 28(9.33%) | 9.75E-14 |
ko04650 | Natural killer cell mediated cytotoxicity | 27(9.00%) | 1.50E-08 |
ko04142 | Lysosome | 12(4.00%) | 2.26E-03 |
ko04110 | Cell cycle | 12(4.00%) | 1.37E-03 |
ko04978 | Mineral absorption | 8(2.67%) | 2.40E-04 |
ko05130 | Pathogenic Escherichia coli infection | 8(2.67%) | 1.49E-03 |
ko00531 | Glycosaminoglycan degradation | 6(2.00%) | 8.14E-06 |
ko00600 | Sphingolipid metabolism | 6(2.00%) | 3.45E-03 |
ko00260 | Glycine, serine and threonine metabolism | 5(1.67%) | 1.06E-03 |
ko03030 | DNA replication | 5(1.67%) | 1.61E-04 |
ko00680 | Methane metabolism | 4(1.33%) | 4.44E-03 |
ko03420 | Nucleotide excision repair | 4(1.33%) | 4.20E-03 |
ko03430 | Mismatch repair | 4(1.33%) | 3.88E-04 |
ko00511 | Other glycan degradation | 3(1.00%) | 3.76E-03 |
ko02026 | Biofilm formation - Escherichia coli | 1(0.33%) | 1.08E-03 |